These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

434 related items for PubMed ID: 23837154

  • 41. Labeled use of efinaconazole topical solution 10% in treating onychomycosis in children and a review of the management of pediatric onychomycosis.
    Gupta AK, Venkataraman M, Shear NH, Piguet V.
    Dermatol Ther; 2020 Jul; 33(4):e13613. PubMed ID: 32418289
    [Abstract] [Full Text] [Related]

  • 42. Efficacy and safety of luliconazole 5% nail solution for the treatment of onychomycosis: A multicenter, double-blind, randomized phase III study.
    Watanabe S, Kishida H, Okubo A.
    J Dermatol; 2017 Jul; 44(7):753-759. PubMed ID: 28332720
    [Abstract] [Full Text] [Related]

  • 43. A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
    Sigurgeirsson B, van Rossem K, Malahias S, Raterink K.
    J Am Acad Dermatol; 2013 Sep; 69(3):416-25. PubMed ID: 23706639
    [Abstract] [Full Text] [Related]

  • 44. Efficacy, safety and tolerability of an optimized avulsion technique with onyster® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study.
    Lahfa M, Bulai-Livideanu C, Baran R, Ortonne JP, Richert B, Tosti A, Piraccini BM, Szepietowski JC, Sibaud V, Coubetergues H, Voisard JJ, Paul C.
    Dermatology; 2013 Sep; 226(1):5-12. PubMed ID: 23467055
    [Abstract] [Full Text] [Related]

  • 45. JUBLIA (Efinaconazole 10% Solution) in the Treatment of Pediatric Onychomycosis.
    Gupta AK, Venkataraman M, Abramovits W, Guenin EP.
    Skinmed; 2021 Sep; 19(3):206-210. PubMed ID: 34303391
    [Abstract] [Full Text] [Related]

  • 46. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
    Elewski BE, Aly R, Baldwin SL, González Soto RF, Rich P, Weisfeld M, Wiltz H, Zane LT, Pollak R.
    J Am Acad Dermatol; 2015 Jul; 73(1):62-9. PubMed ID: 25956661
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Efficacy and Safety of Efinaconazole 10% Solution in the Treatment of Onychomycosis in Diabetic Patients.
    Shofler D, Hamedani E, Seun J, Navarrete R, Thamby R, Harkless L.
    Clin Podiatr Med Surg; 2020 Apr; 37(2):401-407. PubMed ID: 32146992
    [Abstract] [Full Text] [Related]

  • 50. Managing Assessments and Expectations: Patient Responses Following Therapy With Efinaconazole Topical Solution, 10%.
    Bhatia N.
    J Drugs Dermatol; 2015 Jul; 14(7):694-8. PubMed ID: 26151785
    [Abstract] [Full Text] [Related]

  • 51. A phase I/II randomized, double-blind, placebo-controlled, dose-ranging study evaluating the efficacy, safety and pharmacokinetics of ravuconazole in the treatment of onychomycosis.
    Gupta AK, Leonardi C, Stoltz RR, Pierce PF, Conetta B, Ravuconazole onychomycosis group.
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):437-43. PubMed ID: 15987289
    [Abstract] [Full Text] [Related]

  • 52. Efinaconazole Topical Solution, 10% Efficacy in Patients with Onychomycosis and Coexisting Tinea Pedis.
    Markinson B, Caldwell B.
    J Am Podiatr Med Assoc; 2015 Sep; 105(5):407-11. PubMed ID: 26429609
    [Abstract] [Full Text] [Related]

  • 53. Efficacy and safety of topical terbinafine 10% solution (MOB-015) in the treatment of mild to moderate distal subungual onychomycosis: A randomized, multicenter, double-blind, vehicle-controlled phase 3 study.
    Gupta AK, Surprenant MS, Kempers SE, Pariser DM, Rensfeldt K, Tavakkol A.
    J Am Acad Dermatol; 2021 Jul; 85(1):95-104. PubMed ID: 32585278
    [Abstract] [Full Text] [Related]

  • 54. Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
    Bradley MC, Leidich S, Isham N, Elewski BE, Ghannoum MA.
    Mycoses; 1999 Jul; 42 Suppl 2():105-10. PubMed ID: 10865915
    [Abstract] [Full Text] [Related]

  • 55. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK, Lynde CW, Konnikov N.
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [Abstract] [Full Text] [Related]

  • 56. Tavaborole topical solution, 5% for the treatment of toenail onychomycosis.
    Zane LT, Plattner J, Chanda S, Coronado D, Merchant T, Alley MR, Gupta AK.
    Drugs Today (Barc); 2015 Oct; 51(10):599-607. PubMed ID: 26583302
    [Abstract] [Full Text] [Related]

  • 57. Tavaborole in Difficult-to-Treat Onychomycosis Cases: A Post-hoc Assessment of Phase III Subjects.
    Aly R, Gupta AK, Winter T, Zane LT, Vlahovic T.
    J Drugs Dermatol; 2017 Oct 01; 16(10):1016-1021. PubMed ID: 29036255
    [Abstract] [Full Text] [Related]

  • 58. Characteristics and Efficacy of Two Topical Therapeutic Agents for Onychomycosis.
    Kawai M.
    Med Mycol J; 2019 Oct 01; 60(3):71-74. PubMed ID: 31474693
    [Abstract] [Full Text] [Related]

  • 59. Topical Treatment of Onychomycosis and Clinically Meaningful Outcomes.
    Gupta AK, Korotzer A.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1260-1266. PubMed ID: 27741345
    [Abstract] [Full Text] [Related]

  • 60. Onychomycosis in children: a survey of 46 cases.
    Romano C, Papini M, Ghilardi A, Gianni C.
    Mycoses; 2005 Nov 01; 48(6):430-7. PubMed ID: 16262881
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.